Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Have a think!!

<< Previous

Bullboard Posts

Next >>

Comment by Normandton Apr 17, 2024 6:18am

102 Views

Post# 35993154

RE:RE:RE:RE:RE:RE:Have a think!!

Don't push your luck too far ithno. With your multiple usernames on all the forums/ boards. All your false statements that you have told about Oncy in the past, which I have brought up on you several times, but you denied. The two times I denounced you, because you had conversations with yourself on yahoo, with 2 different usernames, but you forgot to change accounts to respond (and your only argument was to say....we don't care about yahoo). We all know that you are one of the worst liars on the forums/boards, so calm down a little.

You seem to have a very, very short memory. I'll stop here for now

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3